Related Experiment Video

Updated: Jul 15, 2025

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft
08:30

A Porcine Heterotopic Heart Transplantation Protocol for Delivery of Therapeutics to a Cardiac Allograft

Published on: February 14, 2022

2.7K

Expanding the Paradigm for Cardiovascular Palliative Care

Sarah Godfrey1, James N Kirkpatrick2, Daniel B Kramer3

  • 1Division of Cardiology, University of Texas Southwestern Medical Center, Dallas (S.G., M.S.S.).

Circulation
|September 25, 2023
PubMed

Insights

Palliative care improves quality of life for cardiovascular disease (CVD) patients, especially those with heart failure. This review explores its role across all CVD types, advocating for tailored models to enhance patient-centered care.

Area of Science:

  • Cardiology
  • Palliative Care Medicine

Background:

  • Cardiovascular disease (CVD) is a leading global cause of death, with significant morbidity and mortality impacting patient quality of life.
  • Palliative care is established in heart failure management, improving patient-centered outcomes, but its role in other CVDs is less defined.
  • Current guidelines incorporate palliative care for heart failure, yet its application across the spectrum of CVD remains uncertain.

Approach:

  • This review examines the critical role of palliative care across diverse cardiovascular conditions, including ischemic heart disease, valvular disease, arrhythmias, peripheral artery disease, and adult congenital heart disease.
  • It discusses general palliative care practices applicable to all cardiovascular patients and highlights the need for individualized, disease-specific palliative care models.
  • The review identifies barriers to implementing cardiovascular palliative care and proposes a framework for future research and development.

Key Points:

  • Palliative care offers significant benefits beyond heart failure, addressing quality of life and end-of-life care for all cardiovascular disease patients.
  • Tailored palliative care strategies are essential for specific cardiovascular conditions to meet diverse patient needs.
  • Implementing comprehensive cardiovascular palliative care is crucial for improving goal-concordant care.

Conclusions:

  • Palliative care is vital across all stages of cardiovascular disease, from diagnosis to terminal care, enhancing patient well-being.
  • Developing and studying specific cardiovascular palliative care models is necessary to overcome existing barriers and improve patient outcomes.
  • A structured approach is recommended to advance cardiovascular palliative care, ensuring better goal-concordant care for this population.

Keywords:
decision making, sharedpalliative carepatient care planning

More Related Videos

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

8.3K
Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model14:24

Percutaneous Contrast Echocardiography-guided Intramyocardial Injection and Cell Delivery in a Large Preclinical Model

Published on: January 21, 2018

11.7K

Related Concept Videos

Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.5K
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
11
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
9
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
16